Position in JNJ
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$1,283,854,667
+$86,380,018 QoQ
Shares Held
5,055,143
+3.2% QoQ
Ownership
0.210%
of shares outstanding
% of Portfolio
0.80%
of 13F equity value
Holder Rank
#52
of 4,647 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 8%
Shared 0%
None 92%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Derivatives in JNJ
reported options exposure · as of Sep 30, 2022CallValue
$0
CallShares
0
PutValue
$408,400
PutShares
2,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LPL Financial LLC holds $5,886,151,720 across 17 Drug Manufacturers - General names. JNJ ranks #2 (21.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,274,807 | $1,529,041,887 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
5,055,143 | $1,283,854,667 | |
| 3 | ABBV |
AbbVie Inc.
|
4,096,323 | $1,030,798,719 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,836,733 | $493,020,190 | |
| 5 | AMGN |
Amgen Inc
|
1,188,164 | $430,257,947 | |
| 6 | PFE |
Pfizer Inc
|
13,919,821 | $335,189,289 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
3,265,381 | $188,151,253 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
969,813 | $122,526,174 |
All Filings in JNJ
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,283,854,667 | 5,055,143 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $1,197,474,649 | 4,898,849 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $1,043,460,525 | 5,042,090 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $924,831,942 | 4,987,768 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $692,758,062 | 4,535,241 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $712,932,229 | 4,298,916 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $573,108,957 | 3,962,861 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $601,932,975 | 3,714,260 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $492,503,513 | 3,369,619 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $504,126,219 | 3,186,840 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $471,969,845 | 3,011,164 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $451,094,052 | 2,896,270 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $470,830,578 | 2,844,554 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $426,434,140 | 2,751,188 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $435,425,998 | 2,464,908 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $377,310,795 | 2,309,689 | Shares | Sole | 2022-11-14 | |
| 2022-09-30 | $408,400 | 2,500 | Put | Sole | 2022-11-14 | |
| 2022-06-30 | $402,819,360 | 2,269,277 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $380,351,530 | 2,146,090 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $357,725,845 | 2,091,108 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $325,029,732 | 2,012,568 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $328,749,542 | 1,995,566 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $298,460,421 | 1,816,005 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $265,575,130 | 1,687,477 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $203,756,870 | 1,368,598 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $179,191,730 | 1,274,207 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $151,496,849 | 1,155,318 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||